US 6818213
Cancer treatment compositions comprising therapeutic conjugates that bind to aminophospholipids
expired A61KA61K39/395A61K47/6849
Quick answer
US patent 6818213 (Cancer treatment compositions comprising therapeutic conjugates that bind to aminophospholipids) held by The Board of Regents of the University of Texas System expires Mon Nov 11 2024 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.
Key facts
- Applicant
- The Board of Regents of the University of Texas System
- Grant date
- Tue Nov 16 2004 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Nov 11 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 64
- CPC classes
- A61K, A61K39/395, A61K47/6849, A61K51/1027